
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [NBIX] Neurocrine Biosciences Inc
Data updated 2025-May-22 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-22 Thursday
Open | $119.67 | High | $120.10 +0.36% |
---|---|---|---|
Close | $119.12 | Low | $118.39 -1.07% |
Volume | 876 Thousand 0.83x | Volatility | 1.44% |
Change |
$-1.44
-1.19%
|
Streak | ↓ 2 days -3.12% |
20d SMA | $115.54 +3.1% | 50d SMA | $108.87 +9.4% | 100d SMA | $120.00 -0.7% | 200d SMA | $123.27 -3.4% |
RSI | 58 | MACD | 0.31 | ADX | 42.5 | Stochastic Oscillator | 58.2 63.6 |
CCI | 43.0 | ATR | 4.16 | OBV | 63.3 Million | Chaikin A/D | 38.3 Million |
Market Cap | 13.8 B | PEG Ratio | 0.46 | Trailing P/E | 56.2 | Forward P/E | 27 |
Price/Sales (ttm) | 7.44 | Price/Book (mrq) | 6.19 | EV/Revenue (ttm) | 7.01 | EV/EBITDA (ttm) | 36.9 |
% Held by Insiders | 1.00% | % Held by Institutions | 95.36% | Shares Short | 2.48 M | Shares Short (prior month) | 2.18 M |
Short Ratio | 2.72 | Short % of Outstanding | 2.49% | Short % of Float | 2.53% | Shares Short Change (mom) | +13.8% |
Revenue/Share (ttm) | $19.32 | Profit Margin (ttm) | 13.23% | Operating Margin (ttm) | 29.17% | EBITDA (ttm) | 416 M |
Diluted EPS (ttm) | $2.47 | Current Ratio (mrq) | 2.45 | Return on Assets (ttm) | 8.78% | Return on Equity (ttm) | 12.68% |
Qtr Earnings Growth (yoy) | 66.00% | Qtr Revenue Growth (yoy) | 25.00% | Operating Cash Flow (ttm) | 390 M | Free Cash Flow (ttm) | 405 M |
Choose view type
Monthly Performance for Neurocrine Biosciences Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Neurocrine Biosciences Inc up to close of 2025-May-22 at $119.12
2-year Performance Benchmarks for Neurocrine Biosciences Inc:
Related to Neurocrine Biosciences Inc
Information for Neurocrine Biosciences Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-22 on Google
SEC Reports : Quarterly reports around 2025-May-22 on SEC Edgar
Compare Neurocrine Biosciences Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Neurocrine Biosciences Inc
Industry : Biotechnology industry performance which includes Neurocrine Biosciences Inc